Temporin-1Sa [L2,9A;V6A]

General Information


DRACP ID  DRACP00671

Peptide Name   Temporin-1Sa [L2,9A;V6A]

Sequence  FASGIAGMAGKLF

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HepG2 Hepatoblastoma Blastoma IC50>600µM MTT assay 72h 1
THP-1 Childhood acute monocytic leukemia; Acute monoblastic/monocytic leukemia Leukemia IC50>60µM MTT assay 72h 1

Hemolytic Activity  Rat erythrocytes: 50% Hemolysis>200µM; Human erythrocytes: 50% Hemolysis >100µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00671

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C59H92N14O15S

Absent amino acids  CDEHNPQRTVWY

Common amino acids  AG

Mass  148376

Pl  9.7

Basic residues  1

Acidic residues  0

Hydrophobic residues  7

Net charge  1

Boman Index  1745

Hydrophobicity  117.69

Aliphatic Index  83.08

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 28319176

Title  Insight into the mechanism of action of temporin-SHa, a new broad-spectrum antiparasitic and antibacterial agent

Doi 10.1371/journal.pone.0174024

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.